Richard Cerione, PhD
Department of Molecular Medicine
Goldwin Smith Professor of Pharmacology and Chemical Biology
Department of Molecular Medicine
Cornell University College of Veterinary Medicine
Ithaca, NY 14853
C3-155 Veterinary Medical Center
- Ph D, Biochemistry, Rutgers University, 1979
- BA, Biochemistry, Rutgers College, 1973
- 2002-Present, Goldwin Smith Professor of Pharmacology and Chemical Biology, Cornell University
- 1998-Present, Full Professor, Department of Chemistry and Chemical Biology, Cornell University
- 1993-Present, Full Professor, Department of Molecular Medicine, Cornell University
- 1990-1993, Associate Professor, Department of Pharmacology, Cornell University
- 1985-1990, Assistant Professor, Department of Pharmacology, Cornell University
- 1982-1985, Senior Research Associate, Howard Hughes Medical Institute, Duke University Medical Center
- 1979-1982, Postdoctoral Fellow, Department of Chemistry, Cornell University
- Boroughs, L., Antonyak, M., Cerione, R. (2014) A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival.. 289:10115-10125.
- Zhang, J., Antonyak, M., Singh, G., Cerione, R. (2013) A mechanism for the upregulation of EGF receptor levels in glioblastomas.. 3:2008-2020.
- Katt, W., Ramachandran, S., Erickson, J., Cerione, R. (2012) Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation. 11:1269-1278.
- Li, B., Antonyak, M., Zhang, J., Cerione, R. (2012) RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. 31:4740-4749.
- Antonyak, M., Li, B., Boroughs, L., Johnson, J., Druso, J., Bryant, K., Holowka, D., Cerione, R. (2011) Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. 108:4852-4857.
Awards and Honors
- 2013, Chancellor's Award for Excellence in Scholarship and Creative Activities, SUNY
- 2009, American Association for Advancement of Science Fellow, American Association for Advancement of Science
- 2000, Frontiers Lecturer, Case Western University Medical Center
- 1999, Eppley Distinguished Lectureship in Cancer Research, University of Nebraska Medical Center
- 1986-1990, PEW Foundation Biomedical Scholar Award, PEW Foundation
- 1979-1982, National Institutes of Health Postdoctoral Fellow, National Institutes of Health
- 1979, American Cancer Society Postdoctoral Fellowship Award , American Cancer Society
- American Chemical Society
- American Society for Biochemistry and Molecular Biology
- 2014, Juror for Blavatnik Regional Awards for Young Scientists, Member
- 2005, Macromolecular Crystallography at the Cornell High Energy Synchrotron Source (MacCHESS), Principal Investigator
- 2013, Cancer Cell Biology and Signaling Program, Weill Cancer Institute, Co-director
- 2007-2011, NIH Study Section, Molecular Integrative Signal Transduction, Member
- 2001-2008, Scientific Advisory Board Gene Network Sciences, Member
- 1996-2000, NIH Study Section, Cell Biology and Physiology, Member
- 1998, Laboratory of Molecular Biology, National Cancer Institute, Review Committee
- 1991-1997, Scientific Advisory Board of Cornell Biotechnology Institute, Member
- 1996, Department of Defense Breast Cancer Program Study Section, Member